Search company, investor...
Maxxtec company logo

Maxxtec

maxxtec.com

Stage

Other Investors | Alive

About Maxxtec

Maxxtec AG is a developer and manufacturer of components and integrated systems for efficient energy generation from solid biomass, industrial waste heat and other renewable energy sources. Maxxtec AG is the only global player offering entire heat transfer plants and ORC modules from a single source. The company aims to serve customers in more than 45 countries through eight branches and regional offices in Europe as well as 26 representative offices worldwide. Since going into business in 1996, Maxxtec has achieved an average annual growth rate of more than 50 percent. Sales in 2008 amounted to over EUR 30 mn.

Headquarters Location

100 North Washington Street, 4th Floor

Boston, Massachusetts, 02114,

United States

Missing: Maxxtec's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Maxxtec's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Maxxtec

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Maxxtec is included in 1 Expert Collection, including Renewable Energy.

R

Renewable Energy

2,872 items

Includes companies working on technology to support renewable energy generation.

Maxxtec Frequently Asked Questions (FAQ)

  • Where is Maxxtec's headquarters?

    Maxxtec's headquarters is located at 100 North Washington Street, 4th Floor, Boston.

  • What is Maxxtec's latest funding round?

    Maxxtec's latest funding round is Other Investors.

  • Who are the investors of Maxxtec?

    Investors of Maxxtec include next47.

  • Who are Maxxtec's competitors?

    Competitors of Maxxtec include Terra-Gen, Fulcrum BioEnergy, Lynntech, Renew Financial, Garbrook Knowledge Resources and 13 more.

Compare Maxxtec to Competitors

S
Synata Bio

Synata Bio is a biology-based renewable energy company. The company's low-cost process converts a wide variety of abundant feedstocks, such as natural gas, wood, garbage, industrial gases and other carbon-containing materials, into fuels and chemicals. The company has combined best-in-class synthesis gas production and cleaning technologies with its molecular biology and process engineering capabilities to create a synthesis gas fermentation technology platform.

F
Freepower

Freepower develops small scale turbine technology.

A
Alterna Energy

Alterna Energy is a company focused on the manufacturing of biocarbon from products, such as wood, municipal and agricultural waste and tires.Biocarbon, also called biochar or charcoal, is a renewable replacement for coal manufactured for industrial markets. The material is produced from any biomass through carbonization. There are many markets for the product including biochar (agricultural applications), activated biocarbon, and energy pelaims to let.A major application is for bioenergy, where the biocarbon is carbon neutral when utilized to generate heat or electrical energy. Among renewable energy sources, biocarbon also has the special ability to be utilized in a variety of applications beyond simple power generation. Biocarbon can utilized in air and water purification, steel industry and agriculture, among others. Many of these applications also supply exceptional environmental benefits.

InEnTec Logo
InEnTec

InEnTec manufactures equipment used to transform waste products into energy. The Company's plasma-enhanced melter equipment rearranges the molecular structure of waste and transforms it into alternative transportation fuels, electricity and products used in manufacturing.

Edenspace Logo
Edenspace

Edenspace Systems Corporation is a Chantilly, VA based company that has received a grant(s) from the Department of Energy's SBIR/STTR program. The abstract(s) for these grant award(s) are provided as well since they provide insights into Edenspace Systems Corporation's business and areas of expertise. This project seeks to retire mercury from the environment by inducing the formation of insoluble mercury selenide (HgSe) in two recently identified Hg-accumulating plant species. If successful, This project seeks to reduce the cost of cellulosic ethanol and other renewable fuels by ensiling crops that produce enzymes to reduce downstream processing costs. The project will create new value-added revenue opportunities for agricultural producers and ethanol cooperatives and reduce fuel costs for consumers. The project seeks to reduce the cost of cellulosic ethanol and other renewable fuels by ensiling crops that produce enzymes to reduce downstream processing costs. If successful, the project will create new value-added revenue opportunities for agricultural producers and ethanol cooperatives and reduce fuel costs for consumers.

B
Bioprocessing Innovative Company

Bioprocessing Innovative Company is a company that received a STTR Phase I grant for a project entitled: Engineering Clostritrial Fermentation for Biobutanol Production. Their project will develop novel engineered Clostridia strains for fermentation to economically produce butanol as a biofuel from sugars derived from starchy and lignocellulosic biomass. Butanol is an important industrial solvent and potentially a better transportation fuel than ethanol. Recent rising oil prices and limited petroleum resources have generated high interest in the production of biobutanol by anaerobic Clostridial fermentation. However, the conventional acetone-butanol-ethanol (ABE) fermentation has low butanol yield (<20%), butanol concentration (<16 g/L) and reactor productivity (<0.5 g/L*h) due to a strong butanol inhibition, and the fermentation process is difficult to improve due to the complicated metabolic pathways and gene regulation involved in the production microorganisms, mainly Clostridium acetobutylicum. To develop a novel high-butanol producer, Clostridia mutant strains with inactivated ack (acetate kinase) and pta (phosphotransacetylase) will be cloned with an alcohol dehydrogenase gene in Phase I and the mutants will be further adapted in a fibrous bed bioreactor to attain a high butanol tolerance. Functional genomic studies of the mutants and further metabolic engineering and process development will be carried out in Phase II to evaluate the feasibility and advantages of producing butanol from glucose and xylose. The new fermentation process can double the butanol yield and concentration, thus reducing the product cost to an economically competitive level for fuel application. Broader Impact: Currently, butanol is almost exclusively produced via petrochemical routes. Its uses include industrial applications in solvent, rubber monomers and brake fluids. Butanol has also been shown to be a good alternative transportation fuel. Biobutanol will have a great potential to compete with ethanol as a transportation fuel when its production cost is reduced by using advanced fermentation technologies such as metabolically engineered butanol-tolerant mutants. By increasing the butanol yield from glucose and xylose from the current low of <20 % (w/w) to ~40%, the economics of biobutanol can be greatly improved. With the engineered mutants, the productivity and butanol product concentration can also be improved by at least 100%. Overall, the biobutanol product cost can be reduced to less than $2 per gallon. This technology thus can provide an economical and better biofuel than ethanol. This project will focus on generation of value-added products from industrial waste streams and low-cost biomass feedstocks to enhance the economic viability of the biorefinery industry. Successfully developing the proposed butanol fermentation technology will satisfy the public interest, especially in providing a safe, renewable energy, protecting natural resources and the environment, and enhancing economic opportunity and quality of life. There will be job creation throughout the commercial development and manufacturing phases. At least one postdoctoral scholar and one Ph.D. student will be trained in this project. Bioprocessing Innovative Company is a company that received a STTR Phase I grant for a project entitled: A Gas-Solid Spouted Bed Bioreactor for Solid State Fermentation to Produce Enzymes and Biochemicals from Plant Biomass. Their research project will develop a gas-solid spouted bed bioreactor (SBB) for solid state fermentations (SSF) to produce hydrolytic enzymes (e.g., amylases, phytase, chitinase) and biochemicals (e.g., lactic acid) from solid starch materials. SSF offers higher production rates and easier product recovery compared to submerged fermentation (SmF), along with the ability to use many agricultural commodities and byproducts, such as rice, corn and wheat bran, as substrates. By virtue of its use of plant biomass as a substrate, SSF can become a sustainable system of chemical production from natural resources, thereby providing economic benefit to US agriculture and increasing national competitiveness. The proposed gas-solid spouted bed bioreactor can overcome problems suffered by conventional SSF systems. Using SBB for enzyme production potentially can reduce enzyme costs by more than 75% and thus increase their applications. Commercially, this new solid state fermentation (SFF) process can be used for economical production of industrially important enzymes from solid plant biomass. Hydrolyases such as amylases, cellulases, phytase, and chitinase have wide applications in industry. These enzymes can be more economically produced from plant biomss in SSF using the spouted bed bioreactor. Amylases and many other hydrolase enzymes are used in bioprocessing, including corn wet-milling, which currently generates more than $24.4 billion market value. Reducing the costs of these hydrolyase enzymes is critical to the emerging biorefinery and bio-based industrial products. The gas-solid spouted bed bioreactor (SBB) also can be used in simultaneous saccharification and fermentation processes for biochemicals production from plant biomass containing starch or cellulose. Successfully developing the proposed SBB and SSF technologies will provide sustainable chemical production, protect natural resources and the environment, and enhance economic opportunity and quality of life. The project also will train high quality personnel in the much needed bioprocessing technology areas, and provide an infrastructure for timely commercialization of university research results. There will be job creation throughout the commercial development and manufacturing phases. Bioprocessing Innovative Company is a company that received a SBIR Phase I grant for a project entitled: Production and Separation of Galacto-Oligosaccharides from Lactose for Prebiotic Food Applications. Their project will develop a novel immobilized enzyme process to produce galactooligosaccharides (GOS) from whey lactose for probiotic food applications. The proposed GOS production process involves two immobilized enzyme reactors and product separation by nanofiltration and adsorption chromatography. Two different alpha-galactosidase enzymes with different GOS formation characteristics will be used to optimize GOS production and yield from lactose. The product stream from the second reactor will be sent to a nanofiltration (NF) separation unit, where GOS, lactose, galactose, and glucose could be separated to yield a product with a higher GOS composition. The process for adsorption with activated carbon and ion exchange liquid chromatography will be developed to further purify GOS. The commercial application of this project will be in the emerging probiotic and neutraceutical food market for use by both animals and humans. This market is estimated to be in excess of 2 billion dollars per year. The present use of GOS in foods is limited by the high production costs. These costs are attributed mainly to the high enzyme cost and low oligosaccharide yields (less than 30% w/w). The proposed technology is expected to reduce production costs by at least 50% due by improving reactor productivity and enzyme life. Further, the ability to use cheap whey precursor products (current price range : $ 0.12 - $ 0.40 per lb) to value added GOS product (curent price : $ 4 - $ 5 per lb) will be of great benefit to the diary industry.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.